Joseph Pidala, Ph.D.
Affiliations: | 2014 | Medical Sciences | University of South Florida, Tampa, FL, United States |
Area:
ImmunologyGoogle:
"Joseph Pidala"Parents
Sign in to add mentor| Patricia A. Kruk | grad student | 2014 | University of South Florida | |
| (Achievement of Transplantation Tolerance: Novel Approaches and Mechanistic Insights.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bos S, Murray J, Marchetti M, et al. (2024) ERS/EBMT clinical practice guideline on treatment of pulmonary chronic graft--host disease in adults. The European Respiratory Journal |
| Baumrin E, Shin DB, Mitra N, et al. (2024) Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease. Jama Dermatology |
| Saber W, Bansal A, Li L, et al. (2024) Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102. Jco Oncology Practice. OP2300413 |
| Ho TT, Perkins JB, Gonzalez R, et al. (2024) Association between , and genotype and tacrolimus treatment outcomes among allogeneic HSCT patients. Pharmacogenomics |
| Elmariah H, Otoukesh S, Kumar A, et al. (2023) Sirolimus is an acceptable alternative to tacrolimus for graft-versus-host disease prophylaxis after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide. Transplantation and Cellular Therapy |
| Lee CJ, Wang T, Chen K, et al. (2023) Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy. Transplantation and Cellular Therapy |
| Gillis N, Padron E, Wang T, et al. (2023) A pilot study of donor-engrafted clonal hematopoiesis evolution and clinical outcomes in allogeneic hematopoietic cell transplant recipients using a national registry. Transplantation and Cellular Therapy |
| Im A, Pusic I, Onstad L, et al. (2023) Patient-reported treatment response in chronic graft--host disease. Haematologica |
| Rashid N, Arora M, Jurdi NE, et al. (2023) Frailty in Patients with Chronic Graft-versus-Host Disease. Transplantation and Cellular Therapy |
| Shaw BE, Jimenez-Jimenez AM, Burns LJ, et al. (2022) Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplant cyclophosphamide: follow-up from a National Marrow Donor Program-sponsored prospective clinical trial. Transplantation and Cellular Therapy |